SLS
SELLAS Life Sciences Group Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.650
High
$1.650
Low
$1.650
Volume
2.61M
Company Fundamentals
Trading Stats
Related News
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m
Related Stocks
DECA
Denali Capital Acquisition Corp. Ordinary Shares
CHCO
City Holding Company
RILYN
B. Riley Financial Inc. 6.50% Senior Notes Due 2026
IGT
International Game Technology Ordinary Shares
IDT
IDT Corporation
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.